Entropy Technologies »

Verve Therapeutics shares owned by Entropy Technologies

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Entropy Technologies from 13F filings

Historical chart of Entropy Technologies investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Entropy Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Entropy Technologies

Quarter filed Position value Share count Share price at filing
2023-12-31 $524k 38k 13.94

More positions owned by Entropy Technologies

Constellation Brands Cl A (STZ)
Schlumberger Com Stk (SLB)
FactSet Research Systems (FDS)
Marathon Oil Corporation (MRO)
Humana (HUM)
Accenture Plc Ireland Shs Class A (ACN)
Monday SHS (MNDY)
Fox Corp Cl A Com (FOXA)
Zscaler Incorporated (ZS)
M&T Bank Corporation (MTB)
Shift4 Pmts Cl A (FOUR)
Cintas Corporation (CTAS)
ResMed (RMD)
Intel Corporation (INTC)
Advanced Micro Devices (AMD)

View all positions for Entropy Technologies

Top funds holding Verve Therapeutics

Alphabet
ARK Investment Management
Vanguard Group
Federated Investors
Casdin Capital
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Jpmorgan Chase & Co
Arch Venture Corp
Redmile Group
Baker Bros. Advisors
EcoR1 Capital
BVF
Palo Alto Investors
Citadel Advisors

View all funds holding Verve Therapeutics